Yesterday, the FDA approved the first skin patch version of Exelon, a drug to treat mild or moderate dementia in patients with Alzheimer's.
The new Exelon patch sounds like a wonderful idea; however, based on my experience with Mom, I don't know whether it would have been an effective treatment. I provide that response due to a 2005 situation when Mom was experiencing chest pains. The doctor couldn't find anything wrong after Mom visited the emergency room; just to be on the safe side,...
On Monday, Novartis, a pharmaceutical giant, received U.S. approval for the Exelon Patch, which delivers a treatment for Alzheimer's... Read more »
This is a study to evaluate the safety of switching from Aricept to an Exelon patch in patients with Alzheimer's disease. This national study is... Read more »
This is a study to determine the safety and tolerability of switching from Aricept to the Exelon patch in patients with probable Alzheimer's disease.... Read more »
The first skin patch to deliver medication to Alzheimer's patients could be available soon, a researcher reports. The patch, which delivers the... Read more »
Source: First DataBank
Generic Name: RIVASTIGMINE PATCH - TRANSDERMAL Pronounced: (riv-uh-STIG-meen) Uses Rivastigmine is used to treat mild to moderate forms of... Read more »
Source: First DataBank
Generic Name: RIVASTIGMINE SOLUTION - ORAL Pronounced: (riv-uh-STIG-meen) Side Effects Nausea, vomiting, stomach pain, loss of appetite,... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
